Skip to main content
OpenTrials
Completed

NCT Number: NCT02286778

Eradication of Malignant Carcinoma in the Breast Tissue

The purpose of this study is to confirm the findings of an early study and expand our knowledge of treating Malignant Carcinoma in the Breast Tissue Using an ATP (Adenosine-5'-Triphosphate) Inhibitor.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Breast Cancer Breast Diseases Breast Neoplasms Neoplasms Neoplasms by Site Skin Diseases Skin and Connective Tissue Diseases

Age range

35 year–75 year

Sex eligibility

Female

Study type

Interventional

Phase

Phase 2 / Phase 3

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Clinical diagnosis of breast cancer
  • Referred to the study by their treating physician

Exclusion criteria

  • Any type of treatment for breast cancer before starting the study

Treatment and study plan

Acetogenins

Dietary Supplement

Acetogenins BID for 12 months

Placebo

Dietary Supplement

Primary outcomes

  1. Number of participants tumor free

    Time frame: 12 months

    assessed by MRI

Sponsors and collaborators

Lead sponsor

Optimal Health Research

Other

Registry information

Official study title

The Eradication of Malignant Carcinoma in the Breast Tissue Using an ATP (Adenosine-5'-Triphosphate) Inhibitor

Important dates

Study start
2016
Primary completion
2017
Study completion
2017
First posted
Nov 10, 2014
Registry last updated
Aug 3, 2017

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.